Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000892569-04-000338
Filing Date
2004-03-15
Accepted
2004-03-15 16:45:43
Documents
8
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K FOR PERIOD ENDED 12/31/03 a97319e10vk.htm 10-K 1420115
3 EXHIBIT 10.30 a97319exv10w30.txt EX-10.30 62019
4 EXHIBIT 10.31 a97319exv10w31.txt EX-10.31 15969
5 EXHIBIT 21 a97319exv21.txt EX-21 3447
6 EXHIBIT 23 a97319exv23.htm EX-23 1182
7 EXHIBIT 31.1 a97319exv31w1.htm EX-31.1 5063
8 EXHIBIT 31.2 a97319exv31w2.htm EX-31.2 5027
9 EXHIBIT 32.1 a97319exv32w1.htm EX-32.1 3344
  Complete submission text file 0000892569-04-000338.txt   1518677
Mailing Address 3300 HYLAND AVE COSTA MESA CA 92626
Business Address 3300 HYLAND AVE COSTA MESA CA 92626 7145450100
VALEANT PHARMACEUTICALS INTERNATIONAL (Filer) CIK: 0000930184 (see all company filings)

EIN.: 330628076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-11397 | Film No.: 04670082
SIC: 2834 Pharmaceutical Preparations